Hoba Therapeutics ApS — Credit Rating and Financial Key Figures

Hoba Therapeutics ApS (CVR number: 38231170) is a company from KØBENHAVN. The company recorded a gross profit of -20860.2 kDKK in 2023. The operating profit was -30.6 mDKK, while net earnings were -27.8 mDKK. The profitability of the company measured by Return on Assets (ROA) was -42.9 %, which can be considered poor and Return on Equity (ROE) was -65.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 75.5 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Hoba Therapeutics ApS's liquidity measured by quick ratio was 9.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.